The William Harvey Research Institute


The William Harvey Research Institute was founded by the Nobel Laureate Sir John Vane, FRS in 1985. It was established at St. Bartholomew's Hospital with initial financial support from Glaxo. Sir David Jack, former head of Glaxo, was the first Chairman of the Trustees of the William Harvey Research Institute (1995-2000). Pharmaceutical companies from Europe, USA and Japan have funded major research programmes, and the Institute is now world-renowned as a centre of excellence for cardiovascular and inflammation research. In 1996, the Institute became part of Barts and the Royal London School of Medicine and Dentistry (Queen Mary University).

Today, the William Harvey Research Institute has more than 350 researchers and is one of the leading centres for pharmacological research in the United Kingdom. Several senior scientists within the Institute are among the 100-leading pharmacologists in the World (see www.isihighlycited.com) and the Institute is ranked among the Top 20 Pharmacological Research institutions (based on citations) in the World (according to The Scientist, 2004).

Registered Users

Related Websites

William Harvey Research Ltd is not responsible for the content of external internet sites